634 Results for "

first

" in MedChemExpress (MCE) Product Catalog:
Products (634)

634 Results for "first" in MCE Product Catalog:

304
304 Publications Verification
Cat. No.: HY-13030
CAS No.: 1268524-70-4
Purity:  99.90%
Synonyms: JQ1
(+)-JQ-1 (JQ1), a chemical probe, is a potent, specific, CNS-penetrant and reversible BET bromodomain inhibitor, with IC50s of 77 and 33 nM for the first and second bromodomain (BRD4(1/2)) . (+)-JQ-1 also activates autophagy .
loading...
    loading...
270
270 Cited Publications
Cat. No.: HY-10227
CAS No.: 179324-69-7
Purity:  99.91%
Synonyms: PS-341; LDP-341; NSC 681239
Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Bortezomib can be used for the study of multiple myeloma (MM) . Bortezomib effectively inhibits TREM2 expression in tumor-associated macrophages (TAMs) .
loading...
    loading...
121
121 Cited Publications
Cat. No.: HY-114277
CAS No.: 2296729-00-3
Purity:  99.94%
Synonyms: AMG-510
Target:  

Ras

Research Areas:  

Cancer

Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib leads to the regression of KRAS G12C‑mutated locally advanced or metastatic non‑small cell lung cancer (NSCLC) .
loading...
    loading...
112
112 Cited Publications
Cat. No.: HY-134836
CAS No.: 2499663-01-1
Purity:  99.86%
Target:  

Apoptosis METTL3

Research Areas:  

Cancer

STM2457 is a first-in-class, highly potent, selective and orally active METTL3 inhibitor with an IC50 of 16.9 nM. STM2457 can be used for the research of acute myeloid leukaemia (AML) .
loading...
    loading...
110
110 Cited Publications
Cat. No.: HY-12248
CAS No.: 1439399-58-2
Purity:  99.82%
Synonyms: CB-839
Target:  

Glutaminase Autophagy

Research Areas:  

Cancer

Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity .
loading...
    loading...
110
110 Cited Publications
Cat. No.: HY-12248A
CAS No.: 1874231-60-3
Synonyms: CB-839 hydrochloride
Target:  

Glutaminase Autophagy

Research Areas:  

Cancer

Telaglenastat (CB-839) hydrochloride is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat hydrochloride selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat hydrochloride inudces autophagy and has antitumor activity .
loading...
    loading...
104
104 Cited Publications
Cat. No.: HY-12057
CAS No.: 918504-65-1
Purity:  99.85%
Synonyms: PLX4032; RG7204; RO5185426
Target:  

Raf Autophagy

Research Areas:  

Cancer

Vemurafenib (PLX4032) is a first-in-class, selective, potent inhibitor of B-RAF kinase, with IC50s of 31 and 48 nM for RAF V600E and c-RAF-1, respectively . Vemurafenib induces cell autophagy .
loading...
    loading...
91
91 Cited Publications
Cat. No.: HY-14275
CAS No.: 52-53-9
Purity:  98.96%
Synonyms: (±)-Verapamil; CP-16533-1
Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research .
loading...
    loading...
91
91 Cited Publications
Cat. No.: HY-A0064
CAS No.: 152-11-4
Synonyms: (±)-Verapamil hydrochloride; CP-16533-1 hydrochloride
Verapamil hydrochloride ((±)-Verapamil hydrochloride) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil hydrochloride also inhibits CYP3A4. Verapamil hydrochloride has the potential for high blood pressure, heart arrhythmias and angina research .
loading...
    loading...
89
89 Cited Publications
Cat. No.: HY-100487
CAS No.: 1450833-55-2
Purity:  98.38%
Synonyms: MLN7243
Research Areas:  

Cancer

TAK-243 (MLN7243) is a first-in-class, selective ubiquitin activating enzyme, UAE (UBA1) inhibitor (IC50=1 nM), which blocks ubiquitin conjugation, disrupting monoubiquitin signaling as well as global protein ubiquitination. TAK-243 (MLN7243) induces endoplasmic reticulum (ER) stress, abrogates NF-κB pathway activation and promotes apoptosis .
loading...
    loading...
56
56 Cited Publications
Cat. No.: HY-10394
CAS No.: 165800-03-3
Purity:  99.95%
Synonyms: PNU-100766
Target:  

Bacterial Antibiotic

Research Areas:  

Infection Cancer

Linezolid (PNU-100766) is the first member of the class of oxazolidinone synthetic antibiotic. Linezolid acts by inhibiting the initiation of bacterial protein synthesis. Linezolid is used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics .
loading...
    loading...
52
52 Cited Publications
Cat. No.: HY-12861
CAS No.: 1542705-92-9
Purity:  99.90%
Target:  

p97

Research Areas:  

Cancer

CB-5083 is a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase/VCP. CB-5083 selectively inhibits p97 through its D2 site with the IC50 of 11 nM .
loading...
    loading...
50
50 Cited Publications
Cat. No.: HY-109025A
CAS No.: 1985605-59-1
Purity:  99.68%
Synonyms: Baloxavir acid; S-033447
Target:  

Influenza Virus

Research Areas:  

Infection Cancer

Baloxavir (Baloxavir acid), derived from the proagent Baloxavir marboxil, is a first-in-class, potent and selective cap-dependent endonuclease (CEN) inhibitor within the polymerase PA subunit of influenza A and B viruses. Baloxavir inhibits viral RNA transcription and replication and has potently antiviral activity .
loading...
    loading...
37
37 Cited Publications
Cat. No.: HY-12481
CAS No.: 1523406-39-4
Purity:  99.74%
Target:  

PI3K Autophagy

Research Areas:  

Cancer

SAR405 is a first-in-class, selective, and ATP-competitive PI3K class III (PIK3C3) isoform Vps34 inhibitor (IC50=1.2 nM; Kd=1.5 nM). SAR405 inhibits autophagy induced either by starvation or by mTOR inhibition. Anticancer activity .
loading...
    loading...
34
34 Cited Publications
Cat. No.: HY-111789
CAS No.: 1858276-04-6
Purity:  98.56%
Synonyms: TAK-981
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Inflammation/Immunology Cancer

Subasumstat (TAK-981) is a first in class and selective inhibitor of the SUMOylation enzymatic cascade, with potential immune-activating and antineoplastic activities .
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-14865
CAS No.: 389139-89-3
Purity:  99.85%
Synonyms: PTK 0796; Amadacycline
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Omadacycline (PTK 0796), a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections .
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-14865B
CAS No.: 1075240-43-5
Purity:  99.37%
Synonyms: PTK 0796 tosylate; Amadacycline tosylate
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Omadacycline (PTK 0796) tosylate, a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline tosylate acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline tosylate possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline tosylate can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections .
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-14865C
CAS No.: 1196800-39-1
Purity:  99.47%
Synonyms: PTK0796 hydrochloride; Amadacycline hydrochloride
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Omadacycline (PTK 0796) hydrochloride, a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline hydrochloride acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline hydrochloride possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline hydrochloride can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-120934
CAS No.: 1358099-18-9
Purity:  99.92%
Research Areas:  

Inflammation/Immunology

C25-140, a first-in-class, orally active, and fairly selective TRAF6-Ubc13 inhibitor, directly binds to TRAF6, and blocks the interaction of TRAF6 with Ubc13. C25-140 lowers TRAF6 activity, reduces NF-κB activation, and combats autoimmunity .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-15826
CAS No.: 1613695-14-9
Purity:  99.60%
SGC-CBP30, a chemical probe, is a potent and highly selective CBP/p300 bromodomain (Kds of 21 nM and 32 nM for CBP and p300, respectively) inhibitor, displaying 40-fold selectivity over the first bromodomain of BRD4 [BRD4(1)] bound. SGC-CBP30 strongly reduces secretion of IL-17A in Th17 cells and has anti-inflammatory effects .
loading...
    loading...